| Garth Greenham - Chief Operating Officer & President Garth Greenham's experience includes 15 years in management with Johnson & Johnson (McNeil Pharmaceutical), where he directed many key global product markets in the human health care area. After Johnson & Johnson, Mr. Greenham became director of sales, marketing and operations for Aqua Health Ltd. where, over a nine-year period, he helped the company grow into the world leader in the field of animal vaccines, primarily aquaculture. Aqua Health was a subsidiary of Cobequid Life Sciences, a TSE-listed company purchased in 2000 by Novartis Inc. He subsequently served as president and director of the post-acquisition company. Mr. Greenham is a co-founder of Phycobiologics Inc. (recently acquired by Functional Technologies) and currently also serves on the board of the Prince Edward Island BioAlliance. As Functional Technologies' chief operating officer, he is responsible for directing the strategic planning and execution of commercial production, and the sales rollout of the company's proprietary yeast and next-generation food and health technologies products. |